1 Study Coverage
    1.1 Influenza Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Market by Application
        1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Influenza Vaccine Sales by Region
        2.4.1 Global Influenza Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Influenza Vaccine by Region (2023-2028)
    2.5 Global Influenza Vaccine Revenue by Region
        2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Influenza Vaccine Sales by Manufacturers
        3.1.1 Global Top Influenza Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Vaccine in 2021
    3.2 Global Influenza Vaccine Revenue by Manufacturers
        3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2021
    3.3 Global Influenza Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Influenza Vaccine Sales by Type
        4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Influenza Vaccine Revenue by Type
        4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Influenza Vaccine Price by Type
        4.3.1 Global Influenza Vaccine Price by Type (2017-2022)
        4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Influenza Vaccine Sales by Application
        5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Influenza Vaccine Revenue by Application
        5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Influenza Vaccine Price by Application
        5.3.1 Global Influenza Vaccine Price by Application (2017-2022)
        5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Influenza Vaccine Market Size by Type
        6.1.1 North America Influenza Vaccine Sales by Type (2017-2028)
        6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028)
    6.2 North America Influenza Vaccine Market Size by Application
        6.2.1 North America Influenza Vaccine Sales by Application (2017-2028)
        6.2.2 North America Influenza Vaccine Revenue by Application (2017-2028)
    6.3 North America Influenza Vaccine Market Size by Country
        6.3.1 North America Influenza Vaccine Sales by Country (2017-2028)
        6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Influenza Vaccine Market Size by Type
        7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028)
    7.2 Europe Influenza Vaccine Market Size by Application
        7.2.1 Europe Influenza Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Influenza Vaccine Revenue by Application (2017-2028)
    7.3 Europe Influenza Vaccine Market Size by Country
        7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Influenza Vaccine Market Size by Type
        8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Influenza Vaccine Market Size by Application
        8.2.1 Asia Pacific Influenza Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Influenza Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Influenza Vaccine Market Size by Region
        8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Influenza Vaccine Market Size by Type
        9.1.1 Latin America Influenza Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Influenza Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Influenza Vaccine Market Size by Application
        9.2.1 Latin America Influenza Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Influenza Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Influenza Vaccine Market Size by Country
        9.3.1 Latin America Influenza Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Influenza Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Influenza Vaccine Market Size by Type
        10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Influenza Vaccine Market Size by Application
        10.2.1 Middle East and Africa Influenza Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Influenza Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Influenza Vaccine Market Size by Country
        10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CSL
        11.1.1 CSL Corporation Information
        11.1.2 CSL Overview
        11.1.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CSL Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CSL Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Sanofi Pasteur
        11.3.1 Sanofi Pasteur Corporation Information
        11.3.2 Sanofi Pasteur Overview
        11.3.3 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Pasteur Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Pasteur Recent Developments
    11.4 Mylan
        11.4.1 Mylan Corporation Information
        11.4.2 Mylan Overview
        11.4.3 Mylan Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mylan Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mylan Recent Developments
    11.5 Hulan Bio
        11.5.1 Hulan Bio Corporation Information
        11.5.2 Hulan Bio Overview
        11.5.3 Hulan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hulan Bio Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hulan Bio Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Corporation Information
        11.6.2 AstraZeneca Overview
        11.6.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 AstraZeneca Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 AstraZeneca Recent Developments
    11.7 CCBIO
        11.7.1 CCBIO Corporation Information
        11.7.2 CCBIO Overview
        11.7.3 CCBIO Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 CCBIO Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 CCBIO Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Influenza Vaccine Industry Chain Analysis
    12.2 Influenza Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Influenza Vaccine Production Mode & Process
    12.4 Influenza Vaccine Sales and Marketing
        12.4.1 Influenza Vaccine Sales Channels
        12.4.2 Influenza Vaccine Distributors
    12.5 Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Influenza Vaccine Industry Trends
    13.2 Influenza Vaccine Market Drivers
    13.3 Influenza Vaccine Market Challenges
    13.4 Influenza Vaccine Market Restraints
14 Key Findings in The Global Influenza Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Trivalent Influenza Vaccine
    Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
    Table 4. Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Influenza Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Influenza Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Influenza Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Influenza Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Influenza Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Influenza Vaccine Price by Manufacturers (2017-2022) &(USD/Doses)
    Table 19. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2021)
    Table 21. Influenza Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Influenza Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Influenza Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Influenza Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Influenza Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Influenza Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Influenza Vaccine Revenue Share by Type (2023-2028)
    Table 33. Influenza Vaccine Price by Type (2017-2022) & (USD/Doses)
    Table 34. Global Influenza Vaccine Price Forecast by Type (2023-2028) & (USD/Doses)
    Table 35. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Influenza Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Influenza Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Influenza Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Influenza Vaccine Revenue Share by Application (2023-2028)
    Table 43. Influenza Vaccine Price by Application (2017-2022) & (USD/Doses)
    Table 44. Global Influenza Vaccine Price Forecast by Application (2023-2028) & (USD/Doses)
    Table 45. North America Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. CSL Corporation Information
    Table 106. CSL Description and Major Businesses
    Table 107. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 108. CSL Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. CSL Recent Developments
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Major Businesses
    Table 112. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 113. GSK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GSK Recent Developments
    Table 115. Sanofi Pasteur Corporation Information
    Table 116. Sanofi Pasteur Description and Major Businesses
    Table 117. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 118. Sanofi Pasteur Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Sanofi Pasteur Recent Developments
    Table 120. Mylan Corporation Information
    Table 121. Mylan Description and Major Businesses
    Table 122. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 123. Mylan Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Mylan Recent Developments
    Table 125. Hulan Bio Corporation Information
    Table 126. Hulan Bio Description and Major Businesses
    Table 127. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 128. Hulan Bio Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Hulan Bio Recent Developments
    Table 130. AstraZeneca Corporation Information
    Table 131. AstraZeneca Description and Major Businesses
    Table 132. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 133. AstraZeneca Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. AstraZeneca Recent Developments
    Table 135. CCBIO Corporation Information
    Table 136. CCBIO Description and Major Businesses
    Table 137. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 138. CCBIO Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. CCBIO Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Influenza Vaccine Distributors List
    Table 143. Influenza Vaccine Customers List
    Table 144. Influenza Vaccine Market Trends
    Table 145. Influenza Vaccine Market Drivers
    Table 146. Influenza Vaccine Market Challenges
    Table 147. Influenza Vaccine Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Vaccine Product Picture
    Figure 3. Global Influenza Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Influenza Vaccine Market Share by Application in 2021 & 2028
    Figure 6. For Children (6 months to 3 years)
    Figure 7. For Adults and Children over 3 years
    Figure 8. Influenza Vaccine Report Years Considered
    Figure 9. Global Influenza Vaccine Sales 2017-2028 (M Doses)
    Figure 10. Global Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Influenza Vaccine Revenue 2017-2028 (US$ Million)
    Figure 12. Global Influenza Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
    Figure 14. Global Influenza Vaccine Sales Market Share by Region (2023-2028)
    Figure 15. North America Influenza Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 16. North America Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Influenza Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 18. Europe Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Influenza Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 20. Asia-Pacific Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Influenza Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 22. Latin America Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Influenza Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 24. Middle East & Africa Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Influenza Vaccine in the World: Market Share by Influenza Vaccine Revenue in 2021
    Figure 27. Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 29. Global Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 30. Global Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 31. Global Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 32. North America Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 33. North America Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 34. North America Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 35. North America Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 37. North America Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 38. U.S. Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 41. Europe Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 43. Europe Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 45. Europe Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 46. Germany Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 47. France Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Influenza Vaccine Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Influenza Vaccine Revenue Share by Region (2017-2028)
    Figure 57. China Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. India Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 71. Latin America Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 72. Mexico Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Influenza Vaccine Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Influenza Vaccine Revenue Share by Country (2017-2028)
    Figure 81. Turkey Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Influenza Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Influenza Vaccine Value Chain
    Figure 85. Influenza Vaccine Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed